Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers
NCT05833672
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Immunotherapy
Interventions
DRUG:
Terelizumab
DRUG:
CapeOx
Sponsor
fan li